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Abstract
There has been increased interest in discovering combinations of single-nucleotide polymorphisms (SNPs) that are strongly
associated with a phenotype even if each SNP has little individual effect. Efficient approaches have been proposed for
searching two-locus combinations from genome-wide datasets. However, for high-order combinations, existing methods
either adopt a brute-force search which only handles a small number of SNPs (up to few hundreds), or use heuristic search
that may miss informative combinations. In addition, existing approaches lack statistical power because of the use of
statistics with high degrees-of-freedom and the huge number of hypotheses tested during combinatorial search. Due to
these challenges, functional interactions in high-order combinations have not been systematically explored. We leverage
discriminative-pattern-mining algorithms from the data-mining community to search for high-order combinations in case-
control datasets. The substantially improved efficiency and scalability demonstrated on synthetic and real datasets with
several thousands of SNPs allows the study of several important mathematical and statistical properties of SNP
combinations with order as high as eleven. We further explore functional interactions in high-order combinations and reveal
a general connection between the increase in discriminative power of a combination over its subsets and the functional
coherence among the genes comprising the combination, supported by multiple datasets. Finally, we study several
significant high-order combinations discovered from a lung-cancer dataset and a kidney-transplant-rejection dataset in
detail to provide novel insights on the complex diseases. Interestingly, many of these associations involve combinations of
common variations that occur in small fractions of population. Thus, our approach is an alternative methodology for
exploring the genetics of rare diseases for which the current focus is on individually rare variations.
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Introduction
Genotype-phenotype association studies, from both targeted
and genome-wide data, have contributed to our ability to identify
genetic variants that are associated with disease. Although an
increasing number of studies have found single-nucleotide
polymorphisms (SNPs) that have statistically significant association
with diseases, most of them either have small effects on disease risk
[1–3] or often explain only a small part of the population [4–7].
Thus, there has been increased interest in discovering combina-
tions of SNPs that are strongly associated with a phenotype even if
each SNP has little or even no individual effect [8–12]. Our goal is
to discover and study such combinations of SNPs to complement
existing approaches for univariate analysis or pathway/network
enrichment-based approaches that are built upon univariate
statistics [13–16]. In particular, as pursued by [17–23], we focus
on discovering SNP combinations, especially high-order ones
beyond size 2, that are strongly associated with a phenotype and
yield information on interpretable statistical and functional
interactions.
There are two challenges in finding SNP combinations that are
highly associated with a phenotype from a large number of SNPs.
The first arises from the combinatorial nature of the problem, i.e.
there are exponentially increasing number of combinations as the
order goes higher. This is even more problematic if a large number
of permutation tests are used to correct for multiple hypothesis
tests [13,24,25]. Given a GWAS dataset with hundreds of
thousands of SNPs, even the examination of pair-wise combina-
tions of SNPs is computationally challenging [23], and requires
efficient enumeration algorithms [23,26–28] or specialized hard-
wares [29,30]. Finding higher order SNP combinations [17,31] is
far more computationally expensive and is out of reach for GWAS
datasets. Hence, existing methods mostly explore higher order
SNP combinations with datasets that only have tens or few
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heuristic-based greedy search. Brute-force approaches such as
multifactor dimensionality reduction (MDR [17]), or the combi-
natorial partitioning method (CPM [19]) can guarantee the
completeness of the search, which is important in detecting SNP
combinations with weak marginal effects [22]. However, these
brute-force approaches can handle only a relatively small number
of SNPs (tens or hundreds) [17,18,32]. The scalability of recent
approaches [33] has been improved to allow searching for size 3
combinations from about 600 SNPs within two hours. However, it
is still not capable of efficiently handling focus studies that have
thousands of SNPs [34,35], especially for higher order combina-
tions. Greedy search strategies [36–44], although more computa-
tionally efficient than brute-force approaches, risk missing
significant SNP combinations [11,12,23], and rarely discover
high-order combinations beyond size 3 [17], and only from
datasets containing tens or hundreds of SNPs covering a even
smaller number of genes.
The second challenge is that existing approaches for high-order
SNP combination searches lack statistical power. Specifically, due
to the use of statistics with high degree of freedom [31,45] and the
huge number of hypothesis tested with often limited sample sizes,
many high-order combinations of SNPs can be strongly associated
with a disease phenotype by random chance, resulting in a high
false discovery rate [25]. Some existing approaches [10,38,46] use
biological pathways or molecular interaction networks as con-
straints to reduce the number of hypotheses to test and make the
interpretation easier. Essentially, a set of SNPs are considered for
an association test only if the SNPs are located around the genes
that are on a common pathway or interact with each other. A
common limitation of such constraint-based approaches is that,
they may miss novel SNP combinations that are not on known
pathways or interaction subnetworks due to the incompleteness of
biological knowledge. Thus, it calls for a quantitative evaluation on
trade off between the reduction of search space and the risk of
missing informative SNP combinations, and also calls for
alternative constraints that are not limited by existing biological
knowledge.
In this paper, we aim to address both the above challenges.
To improve computational efficiency, we leverage the discrim-
inative pattern mining framework (DPM, originally proposed
[47,48] in the data mining community for mining market basket
data) to efficiently search for high-order SNP combinations from
SNP datasets in focused studies with thousands of SNPs. The
computational efficiency and scalability of DPM is enhanced by
the systematic pruning of the combinatorial search space with anti-
monotonic objective functions. A unique advantage of anti-
monotonicity-based search over brute-force search is that it can
avoid exploring the whole search space (all combinations of SNP
genotypes) by pruning a large number of candidates that cannot
lead to a sufficiently strong association with a phenotype [48,49].
We demonstrate that DPM has substantially improved efficiency
and scalability on a synthetic and three real datasets with several
thousands of SNPs. We observe that most high-order combina-
tions are trivial extensions of their subsets which are not interesting
but consume most of the total computation time, however, there
are indeed high-order combinations that have discriminative
power significantly beyond singleton SNP or low-order SNP
combinations.
To improve the statistical power, we study the effect of two
strategies that reduce the number of high-order combinations
being tested. The first, which does not depend on the use of prior
biological knowledge, is to require an increase in discriminative
power for a combination over its subsets. We demonstrate that
this constraint can reduce the number of hypothesis tests
dramatically and thus enable the discovery of significant
combinations that would have been missed otherwise. The
second strategy, which depends on the known biological
knowledge, is to use gene-set (e.g. pathway) constraints within
the DPM framework. While this approach has been used in
existing work to improve computational efficiency, we quantita-
tively evaluate its effect on enhancing statistical power in
conjunction with the DPM framework.
The improved computational efficiency and statistical power
further enables the discovery of significant high-order SNP
combinations from the three real datasets and then allows the
exploration of functional interactions in high-order SNP
combinations. Specifically, we study the functional interactions
among the genes covered in high-order SNP combinations with
an integrated human functional gene network. We find a positive
connection between the increase of discriminative power of a
SNP combination over its subsets and the functional coherence
among the genes covered in the combination. Such an
observation is beyond the disease-specific functional interactions
studied by existing work that are based on datasets covering a
small number of genes [17] and is supported by the multiple real
datasets used in the paper. In addition to this disease-
independent biological insight, we also interpret several high-
order combinations discovered from the lung cancer [MIM:
211980] dataset and the dataset for studying rejection after
kidney transplant, which provide novel insights beyond univar-
iate or low-order SNP-combination analysis. More generally, we
find that many significant associations are combinations of
common variations that occur in small fractions of population.
This suggests an alternative direction for the exploration of the
genetics of rare diseases, where the current focus is mainly on
analyzing individually rare variations.
Results
Three Real Case-control SNP Datasets and a Synthetic
Dataset
We use three SNP datasets designed for studying different
types of disease phenotypes: (i) short (less than one year) vs. long
(greater than three years) survival of multiple myeloma [MIM:
254500] patients [34] (denoted as Survival), (ii) acute rejection
[MIM: N/A] (within in six months) vs. non-rejection (within
eight years) after kidney transplant [22] (denoted as Kidney), (iii)
lung cancer [MIM: 211980] vs. non-lung cancer (both heavy
smokers) [35] (denoted as Lungcancer). The three datasets were all
collected with a chip [34] targeting 3444 SNPs in 983 genes,
representing cellular functions and pathways that may influence
disease severity at diagnosis, toxicity, progression or other
treatment outcomes. Previous analyses on these three datasets
did not reveal statistically significant single SNPs after correcting
for multiple hypothesis testing, and this study aims to explore if
there are significant (after correcting for multiple hypothesis
testing) associations between combinations of SNPs and disease
phenotypes, especially high-order combinations (with size greater
than 2) that have stronger association beyond single SNPs or
low-order combinations.
Preprocessing and quality control steps are described in the
method section. Table S1 summarizes the number of SNPs after
quality control and the numbers of cases and controls for each of
the datasets. More information on these datasets can be found in
the original papers. All the datasets are available from the Eastern
Cooperative Oncology Group (ECOG) through requests to the
operations office (http://www.ecog.org/, accessed 2012 Feb 20).
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dataset with 70 cases and 70 controls, 2172 SNPs without
differentiation between the cases and controls, and four synthetic
high-order SNP combinations of size 3, 4, 5 and 6 respectively,
that are associated with case-control groupings. (See the methods
section for simulation details).
Note that, the above four datasets have much larger number
of SNPs (ranging from 2172 to 3428) than the datasets used in
previous studies on high-order SNP interactions (tens or
hundreds of SNPs). With these four datasets, we will show that
the proposed framework is substantially more efficient and
scalable than existing approaches. Although the proposed
approach could not directly handle datasets with more than
10,000 SNPs due to the intrinsic computational complexity of
high-order SNP combination search, it is worth noting that tag
SNP selection [50] techniques can be used to first obtain a set of
less redundant SNPs before the use of the proposed approach. In
this way, genome-wide studies with hundreds of thousands of
SNPs could also be analyzed.
The Binary Encoding of a SNP and a Combination of SNPs
We use a binary coding scheme of SNP genotypes, where we
create three binary columns for each SNP (Figure S1). For a single
SNP (X) with three genotypes (homozygous minor (mm),
heterozygous (Mm) and homozygous major (MM).), we create
three binary variables as X~mm, X~mM and X~MM, each
of which is represented as a binary variable indicating if a person’s
genotype for SNP X is mm, mM or MM respectively. Figure S1
illustrates the transformation from categorical encoding to binary
encoding. Note that, this is a lossless transformation because it can
be mapped back to the original SNP genotypes without ambiguity.
As will be shown later, the use of this binary coding is to enable
the efficient traversal of the combinatorial search space in the
discriminative pattern mining (DPM) framework used in the
paper. Although the number of columns increases to three times of
the original number of SNPs, we show the DPM framework has
substantially better efficiency and scalability than existing
approaches that directly search from the categorical SNP
variables. It is worth noting that, binary encoding was also
leveraged in [33], where the authors commented that, while
binary coding may have somewhat weaker power, it does allows
the use of efficient enumeration algorithms and the discovery of
biologically interesting SNP combinations.
Based on the binary coding for each SNP genotype, a
combination of SNPs is essentially a combination of SNP
genotypes. For example, for three SNPs X, Y and Z, a combination
might be X~mm,Y~mM,Z~MM fg : Such a combination is
also called a pattern in this paper, where we use the terms
‘‘pattern’’, ‘‘combination’’ and ‘‘SNP combination’’ interchange-
ably. Following the traditional setup in discriminative pattern
analysis, a pattern is said to be present in a subject only if the
subject’s genotypes match all the SNP genotypes in the pattern,
and absent otherwise. Thus, a combination of SNP genotypes
(multiple SNPs, each contributing one of its genotype) is also
encoded as a binary variable (present or absent). Again, we use this
setup to allow DPM to efficiently perform the search of
combinatorial pattern space. The frequency of a pattern (the
percentage of subjects in which a pattern is present, also called
support) has a mathematical property named anti-monotonicity,
which can be leveraged by DPM to prune most of the
combinatorial search space and only investigate those patterns
that are more likely to have strong association with a disease
phenotype [47,48] (see methods section).
With this binary encoding of a SNP combination, a x2 test of the
association between any combination and a binary phenotype has
a fixed degree of freedom of 1 [33] and is independent of the size
of the combination. Here, the goal is to test the association
between the present and absent of the SNP combination, under
the binary encoding, and a binary phenotype. Note that, other
statistical measures can also be used for similar purpose. This also
implies that the proposed framework can handle datasets with
imbalanced number of cases and controls. The degree of freedom
being 1 is an important advantange for high-order SNP
combination analysis because most real datasets have a limited
number of samples that are insufficient for estimating the
association between a combination of larger size and a disease
phenotype if the statistical measure in use has a degree of freedom
increasing with the size of a combination. The fixed degree of
freedom also allow the direct comparison of the statistics (e.g. x2
statistic or others) of SNP combinations of different sizes, which is
important for quantifying the gain of discriminative power of a
SNP combination with respect to its subsets. For example, the size-
3 combination X~mm,Y~mM,Z~MM fg has three size-2
subsets: Y~mM,Z~MM fg , X~mm,Z~MM fg and
X~mm,Y~mM fg :
Illustrative Examples of High-order Discriminative SNP
Combinations
After describing the above binary encoding of a SNP
combination, we first illustrate two examples of high-order SNP
combination shown in Figures 1 (PA and PB, generated with the
method developed in [51]) before presenting the efficient search
algorithm. PA is a pattern containing four SNPs (separated by
vertical green lines) over 70 cases and 70 controls, which are
separated by a horizontal yellow line (cases top, controls bottom).
The black color indicates presence (19s) and the white indicates
absence (09s) of one of the three genotypes of a SNP. The x2
statistic, odds and the {log10 fisher exact test p-value of the
synthetic combination (as a binary encoded single variable as
described above) are (28:7,21:0,7:84): The subfigure in the right
column contains 4 pairs of bars. For each pair, the left bar
(unfilled) and the right bar (filled) indicate the minimal and the
maximal x2 statistics for the size-i (i[ 1,4 ½  ) subsets of the
combination. For the right most pair, both bars are equal since
they both denote the x2 statistic of the SNP combination itself. As
shown, the x2 statistic of PA is higher than all of its subsets, which
makes PA interesting because it provides predictive power beyond
that of its subsets. Thus, it is important to discover this high-order
pattern as a highly confident predictive rule with an odds ratio of
21, rather than discover its subsets.
Similar to PA, pattern PB in Figure 1 also has high
discriminative power in terms of x2 statistic, odds ratios and the
{log10. However, in contrast to PA, pattern PB is actually less
discriminative than one of its size-2 subset (the first two SNP
columns), as reflected by the drop in the x2 statistic in the right
subfigure. Later in this section, we will differentiate these two types
of SNP combinations and show that SNP combinations like PA
provide more information for the functional interactions among
the genes in a SNP combination, while the high discriminative
power of patterns like PB are trivial consequences of their highly
differentiating subsets. Figure S2 shows four high-order SNP
combinations of size-3 to size-6 (generated with [51]) that we
embedded in the synthetic dataset described earlier, all having
higher discriminative power than their subsets. Indeed, such
interesting high-order SNP combinations also exist in real datasets
for studying complex diseases such as cancer, as will be shown in
the result section.
High-Order SNP Combinations and Complex Diseases
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Strong Association with a Phenotype
Withthetwodiscriminative SNPcombinationsshowninFigure1
and the additional examples in Figure S2, we now describe how to
leverage the discriminative pattern mining (DPM) framework to
efficiently search for high-order SNP combinations that have strong
association with a disease phenotype. The DPM mining framework
was originally proposed in the data mining community to efficiently
enumerate combinations of variables and identify those that are
highly predictive [52,53]. DPM builds upon a general search
strategy called Apriori [47], which leverages the anti-monotonicity
of a special type of objective functions for efficient enumeration of
high-order variable combinations (see methods for details).
Conceptually, with an objective function that is anti-monotonic, a
SNP combination satisfies a threshold on the objective function only
if all its subsets satisfies the threshold. In another word, if a
combination does not pass a threshold on the objective function, all
of its supersets can be pruned in the search space and it is
guaranteed that no larger combination that satisfies the threshold
would be missed. This is the key difference between Apriori-based
combinatorial search and brute-force combinatorial search.
In this study, we leverage a recently developed anti-monotonic
objective function SupMaxPair [48] and use it in the Apriori
framework to efficiently search for SNP combinations that are
discriminative between cases and controls. SupMaxPair captures
the association between a SNP combination and a binary disease
phenotype (see the methods section), i.e. the higher SupMaxPairo,
the stronger the SNP combination is associated with the phenotype.
The Apriori framework using SupMaxPair as the objective
function is called SMP [48] and has the advantage of handling
dense and high dimensional data, which addresses the key challenge
in discovering high-order combinations from SNP datasets, i.e. a
fixed high density of 33% as a result of the binary encoding of each
SNP (Each SNP is represented with three binary columns and the
genotype of a sample for each SNP is represented by a 1 in one of
the three columns (assuming there is no missing value). Thus, one
third of the matrix values are 19s (a density of 33%).) and a large
number of SNPs (high dimensionality). This advantage owes to the
Figure 1. Visualization of the two synthetic SNP-genotype combinations and their high-order association with the two classes. The
two subfigures in the left column are the visualization of the genotypes of 4 SNPs separated by vertical green lines, over the 70 cases and 70 controls
separated by a horizontal yellow line. The black color indicates present and the white indicates absent, in the binary format described in the method
section. The x2 statistic, odds ratios and the {log10 fisher exact test p value of the two combinations are (28:7,21:0,7:84) and (25:8,18:6,7:1),
respectively. Each subfigure in the right column contains 4 pairs of bars. For each pair, the unfilled bar and the filled bar indicate the minimal and the
maximal x2 statistics for the size-i (i[ 1,4 ½  ) subsets of the combination. The right most pair, both bars are equal since they both denote the x2 statistic
of the SNP combination itself. Another four examples of high-order discriminative SNP combinations of size-36 are shown in Figure S2 with similar
description as this figure.
doi:10.1371/journal.pone.0033531.g001
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and is the essence of SMP’s better efficeincy and scalablity over
other DPM algorithms.
It is worth noting that Ma et al. [33] is the first that leverages an
Apriori-based algorithm [54] (FPC) for the efficient enumeration
of SNP combinations. However, FPC does not make use of
phenotype information to optimize the search process and thus is
much less efficient and less scalable than SMP, as has been shown
in [48] on differential gene expression analysis and will also be
demonstrated on SNP datasets in the result section of this study.
SMP is part of the framework we implement for this study and is
available on the paper website (http://vk.cs.umn.edu/HSC/,
accessed 2012 Feb 20).
The DPM Framework has Substantially Better Efficiency
and Scalability
We compare the DPM framework with two representative
existing tools for high-order SNP combination discovery: MDR
[17] (http://www.epistasis.org/software.html) and the framework
presented in [33] (denoted as FPC in this paper). For MDR, we
used the Java version (http://sourceforge.net/projects/mdr/) and
used the standard coding, in which each SNP is represented by a
categorical value with three possible values (genotypes). For DPM
and FPC, we use the binary coding. FPC requires an input for the
parameter minsup (the minimum frequency of a pattern in the set
of cases and controls combined). For comparison purpose, we set a
five-hour maximal runtime allowance (Though arbitrary, some
threshold needs to be selected for comparison purpose) for all the
three techniques. Experiments presented here were run on a Linux
machine with 10 Intel(R) Xeon(R) CPUs (2.00GHz) and 100GB
memory.
In the synthetic dataset (described in the method section), there
are 2172 SNPs. The three frameworks need to search through
size-2, size-3, size-4, size-5 and size-6 combinations in order to
discover the four embedded patterns of size-3 to 6. After five
hours, MDR was still enumerating size-3 SNP combinations, and
thus failed to identify the embedded size-4, size-5 and size-6
patterns. FPC could reach size-6 within five hours, but only with a
minsup threshold of 0.9 (With a minsup threshold of 0.8, FPC
could not finish even in 24 hours.), which is so high that none of
the four synthetic patterns were discovered (the frequency of the
four embedded patterns are all below 0.25.). In contrast, the run
time of SMP on the synthetic dataset is around 4 minutes with a
SupMaxPair threshold of 0:15: The threshold of 0.15 was chosen
such that all the four embedded synthetic SNP combinations can
be discovered. At lower threshold, additional discriminative SNP
combinations can be discovered (if they exist), but it will take more
computational time. In practice, one should use a threshold as low
as possible while the computational time is still acceptable (usually
decided after some tests). In addition, given a fixed SupMaxPair
threshold and a fixed number of SNPs, the patterns discovered
from a dataset with larger sample size are expected to be more
statistically significant in term of false discovery rate. Therefore,
given a certain statistical significance cutoff, a lower SupMaxPair
threshold should be used for datasets with larger sample sizes while
the computational time is still acceptable.
The discovered SNP combinations are of size 2 to 10, including
all the four embedded patterns. The substantially better efficiency
of SMP is also observed on the three real datasets, which have
2755–3428 SNPs (Table S1). The substantially better efficiency
and scalability of SMP over FPC and MDR is due to the effective
use of phenotype information in SMP for pruning combination
candidates that are less likely to form a larger discriminative
pattern as discussed in the method section (refer to [48] for further
details). Indeed, the efficiency of the proposed framework (search
as high as size-10 combinations from thousands of SNPs within
one hour) is superior to not just MDR and FPC, but also to several
other existing approaches which can discover up to size-3 SNP
combinations from datasets with hundreds of SNPs
[18,32,33,40,55]. Furthermore, we designed an experiment to test
the scalability of SMP with respect to the sample size. We vary the
sample size (cases and controls combined) from 140 to 5600 in
seven steps (140, 280, 420, 560, 1400, 2800 and 5600) as shown in
Figure (see method section for the details of data simulation). The
first four steps representing one, two, three and four times of the
samples in the first synthetic dataset (used in the comparison with
MDR and FPC), respectively. The last three steps correspond to a
much larger samples sizes in several thousands that represent the
number of samples in most GWAS studies. The running time
shown on the y-axis of Figure S3 shows that the computational
time of SMP increases approximately in a linear manner with
respect to the sample size (recall that the x-axis is not linearly
spaced). This agrees with the theoretical time complexity of
Apriori-based searching algorithms [47] and indicates that SMP is
able to handle datasets with much larger number of samples than
the three real datasets used in this paper.
Note that, the synthetic datasets used above (to demonstrate the
better efficiency and scalability of DPM over MDR and FPC) are
representatives of the three real datasets used in the paper. For
datasets with smaller number of SNPs(e.g. tens or hundreds of SNPs),
MDR and FPC (as well as other similar approaches) have been
compared with other approaches [21,33] and demonstrated to be
scalable (mostly up to size 3 combinations). In this study, we have the
specific focus on datasets with thousands of SNPs such as the three
real datasets or datasets of tag SNPs selected from genome-wide
studies, and we are particularly interested in high-order interaction
(its mathematical and statistical properties as well as functional
insights). Therefore, we will only use DPM in the rest of the analyses.
Identifying High-order SNP Combinations with Stronger
Association than their Subsets
Among the set of discovered SNP combinations discovered by
DPM, some have better discriminative power than their
corresponding subsets (like PA in Figure 1) while some have
similar or lower discriminative power (like PB in Figure 1). A
simple way to quantify the increase of discriminative power of a
SNP combination over its subsets is to take a difference between
the discriminative power of a SNP combination itself and the best
discriminative power among all of its subsets. With the x2 statistic
as the measure for discriminative power, this difference (denoted
as x2
jump) for a pattern a can be formally written as below. Note
that, the x2 statistics of patterns of different sizes all have the
degree of freedom of 1 based on the binary encoding of a SNP
combination presented earlier in this section. Also note that,
among the thresholds we used for SupMaxPair in the paper, the
lowest is 0.15. This implies that the minimum frequency of any
discovered SNP combination is 15% of the number of cases or
controls (refer to the definition of SupMaxPair in the method
section). Thus, the estimation of x2 statistic for any SNP
combination would be based on a frequency of at least 15% of
the number of cases or controls, even for high-order combinations.
x2
jump(a)~x2(a){maxa’5a(x2(a’)): ð1Þ
With the above definition, the x2
jump of the two patterns shown in
Figure 1 are 14.4 and 26.1 and the four patterns in Figure S2 all
High-Order SNP Combinations and Complex Diseases
PLoS ONE | www.plosone.org 5 April 2012 | Volume 7 | Issue 4 | e33531have positive x2
jump values (47.7, 14.4, 6.2 and 4.0 respectively).
Indeed, x2
jump is not a new concept and similar measures based on
other statistics for discriminative power (instead of x2 statistic) have
been studied in data mining literature [56]. More generally,
existing measures of epistasis and genetic interaction [39,45] which
capture the difference between the joint statistic between a SNP
combination and the linear (or independent) addition of the its
subsets, could be used for the same purpose as well. However, they
are not suitable for high-order combinations analysis due to their
increasing degrees of freedom and computational expense as
combination size increases, which thus requires an increasing
number of samples for accurate estimation. In contrast, x2
jump or
similar measures based on other statistics have the advantage of a
fixed degree of freedom (1) and thus are more practical for
measuring the association between high-order combinations and a
phenotype. Furthermore, the requirement of epistasis measures is
more restrictive than measures like x2
jump because the former only
captures non-additive effect while the latter targets the general
combined effect including both linear and non-linear combina-
tions. Indeed, as will be shown in the result section, both linear and
non-linear high-order combinations exist in real datasets, and both
can be highly discriminative with respect to a disease phenotype
and thus are of great interest.
Intuitively, it would be ideal if an algorithm like SMP can
directly differentiate combinations with positive and negative
values and then prune the ones with negative values as early as
possible in the searching process. However, this is a non-trivial task
because the x2
jump does not have the antimonotonicity property
(crucial for the efficient enumeration of high-order combinations
using the Apriori strategy [47]) and thus some combinations with
large positive x2 jump would be missed if they have subsets with
negative x2
jump: Therefore, in this study, we use SMP to first
discover a set of discriminative combinations and then apply a
x2
jump based filtering as a separate step.
Many High-order Patterns are Trivial Extensions of their
Smaller Subsets
We ran DPM on the three real datasets (with SupMaxPair~0:2,
the lowest threshold that DPM can finish within 0.5 hour) and
produced a set of SNP combinations from each dataset. With the
three sets of discovered patterns, we first study a key mathematical
property of high-order patterns, that is, if these combinations provide
additional insights beyond their subsets. Specifically, for each
combination, we calculate its x2{statistic and x2
jump, and summarize
the results in Figure 2, with the three subfigures corresponding to the
three datasets. Each subfigure shows the x2 statistic of each pattern
and the maximal x2 statistic among all of its subsets, for all the
discovered patterns. The x2
jump thresholds of +5 and –5 are indicated
by a red line and a black line respectively, in each subfigure. Clearly,
many large size patterns have negative x2 jump, which indicates that
many high-order patterns are trivial extensions of their smaller
subsets (such as pattern PB in Figure 1). They are not interesting or at
least not informative for either enhancing the predictive power of a
pattern or exploring functional interactions among the patterns in a
SNP. Note that, +5 and –5 are used as two threshold of x2
jump in
Figure 2 just for visualization purpose, while different thresholds are
studied in the separate experiments.
Some High-order Patterns are Highly Discriminative
Beyond Univariate and Low-order SNP-combinations
We also note that there are indeed several high-order
combinations that provide higher discriminative power than any
of their corresponding subsets. Specifically, in the datasets, Kidney
and Lungcancer, there are tens of size-4 and size-5 patterns above
the line of y~xz5: These patterns may indicate high-order
functional gene interactions whose joint genetic variations result in
a stronger association with the disease phenotypes than singletons
and lower-order combinations. Again, +5 and –5 are used as two
threshold of x2
jump in Figure 2 just for visualization purpose, while
different thresholds are studied in separate experiments. The
observation that only a small fraction of high-order patterns have
large x2
jump values motivates the design of targeted search
algorithms that specifically look for patterns with large x2
jump in
addition to high x2: However, this is a non-trivial task as discussed
in the method section.
Many patterns with high x2
jump (e.g. above the line of y~xz5)
in the three datasets have x2{statistics greater than 20, which
corresponds to a low p-value of 10{7: However, because a huge
number of hypotheses were tested in the SMP search, we need to
correct for multiple hypothesis testing. We use a permutation-test
based approach (see methods section) to estimate unbiased and
reliable false discovery rates (FDRs) for the patterns discovered
and shown in Figure 2 (methods section).
Figure 3 shows the x2 statistics and FDRs for the patterns with
x2
jump above 5 (different parameters for x2
jump are studied in
separate experiments), with a layout similar to Figure 2. The
circles with similar color are clustered together, which results from
the size-specific permutation tests which estimate the FDR of a
size-k pattern from the null distribution built with only the random
patterns of size k (see method). We observe that there are several
significant patterns with FDR (w.r.t. x2) below 0.25 discovered
from the datasets Kidney (up to size-4) and Lungcancer (up to size-
5). Note that in Figure 3, we only consider the patterns with high
x2
jump (above the line of y~xz5). We will present a separate
experiment that illustrates the benefit to statistical power of using
x2
jump based filtering where we try different thresholds of x2
jump:
To better understand the effect of sample size on the FDRs of
the patterns discovered from the real datasets. We designed an
experiment with the same synthetic datasets used in the scalability
test (Figure S3). Specifically, we examine the effect of sample size
on the FDRs of the four embedded synthetic SNP combinations of
sizes 3, 4, 5 and 6, respectively. Table S2 summarizes the FDRs of
each pattern in each synthetic datasets with different sample sizes.
The key observation is that, although the FDRs of embedded
patterns are expected to be more significant when the sample size
increases, all the four synthetic patterns have perfect FDR
(,0.002, i.e. no better patterns were found in any of the 500
permutations), when the sample size is above 200. This indicates
that the sample sizes in the two real datasets (Lungcancer and
Kidney) are expected to be good enough for high-order SNP
combination search. However, when the sample size is below 200,
two of the four embedded real patterns (the size-4 one and size-5
one) can not be discovered with significant FDRs. This is also
consistent with our observation on the other real datasets
(Survival), on which no significant SNP combinations were
discovered. Therefore, this new experiments helped the under-
standing of the effect of sample sizes on FDR and also support the
statistical reliability of the patterns discovered from the two real
datasets.
Two Procedures that Generally Enhance Statistical Power
of High-order SNP Combination Discovery
Here, we present the results studying two procedures for
reducing the number of hypothesis tests in DPM, and their effect
on enhancing the statistical power of high-order SNP combination
discovery. The two procedures are: (P1) enforcing a proper
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PLoS ONE | www.plosone.org 6 April 2012 | Volume 7 | Issue 4 | e33531threshold of x2
jump and (P2) using gene-set (e.g. pathway)
constraints. They both have been used in existing literature for
improving the computational efficiency of a combinatorial search
framework [38,45]. However, their effect on improving statistical
power has not been systematically studied. The scalability of DPM
for discovering high-order SNP combinations provides an
opportunity to explore this. The statistical power is indirectly
measured by the number of combinations and unique SNPs
discovered with respect to a specific false discovery rate of 0.25.
(Although somewhat arbitrary, a cutoff is needed. We choose a
relatively high FDR threshold as in [24] because, for high-order
SNP combination discovery which is still at its early stage, the
research focus is more about hypothesis generation instead of
hypothesis verification).
Use of x2
jump based filtering generally improves
statistical power. In Figure 3, the FDRs are estimated only
with those patterns having sufficiently highx2
jump: Here, we study
whether using a x2
jump based pattern filtering improves the
statistical power of the framework. Figure 4 (each circle
represent a SNP combination) compares the FDRs without x2
jump
based filtering (x-axis) and the FDRs with x2
jump filtering (y-axis) for
the Lungcancer (left subfigure) and Kidney (right subfigure)
datasets. We tried three different thresholds for x2
jump (0, 3 and 5)
and found that the results are similar, which suggest the essential
effect of the filtering is to eliminate those patterns with low
negative x2
jump values. The figures shown here are based a
threshold of 5 for x2
jump. We use these two datasets for this
comparison because there are more high-order combinations with
high x2
jump discovered from them (up to size-4 and size-5) and
because none of the pattern discovered from the other dataset
(Survival) have FDR (w.r.t. x2) below 0.25. In both subfigures,
there are several circles sitting below the line y~x, indicating that
these patterns have lower (more significant) FDR (w.r.t. x2) when a
x2
jump filtering was applied compared to the case where x2
jump was
not used. Specifically, there are seven combinations in the right
subfigure (the red ones indicated by the arrow) which have an
insignificant FDR (0.5) when no x2
jump-based filtering was applied,
but low FDRs (around 0.2) when a x2
jump~5 filtering was used.
This comparison demonstrates that x2
jump can enhance the
statistical power of discriminative SNP-combination discovery and
potentially discover SNP combinations that would have been
missed. This can be explained as follows: for a real pattern P of
size-k and a high x2
jump, the use of x2
jump filters out random patterns
in the permutation tests that have high discriminative power but
are trivial extensions of its subsets, which would otherwise penalize
the statistical significance of P: Essentially, the use of x2
jump based
filtering provides a better estimation of the statistical significance of
a pattern with high x2
jump by estimating a more reasonable null
distribution.
As discussed earlier, x2
jump is just one of many possible measures
that quantitatively describes the increment of discriminative power
of a pattern with respect to its subsets. Specifically, the
Figure 2. Comparing the x2 statistic of each pattern with the maximal x2 statistic among all of its subsets. The three subfigures
correspond to the three datasets. Each subfigure shows the x2 statistic of each pattern and the maximal x2 statistic among all of its subsets for all the
discovered patterns. The color of a circle indicates the size of the pattern. The red line and the black line in each subfigure show y~xz5 and
y~x{5 respectively.
doi:10.1371/journal.pone.0033531.g002
Figure 3. The x2 statistics and FDRs for the patterns with x2 jump above 5. The layout follows that of Figure 2. In each subfigure, each circle
is a pattern with the color indicating pattern size. Y-axis is the x2 statistic of a pattern of size-k, and X-axis shows its permutation test-based FDR,
which is size-specific as described in the method section.
doi:10.1371/journal.pone.0033531.g003
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power, or the difference can also be replaced by measures for
statistical epistasis [39,45]. The observations from the above
comparison, where x2
jump is used as a representative, supports the
use of these measures to improve the statistical power of
discriminative SNP combination discovery.
Applying gene-set constraints generally improves
statistical power. As discussed in the introduction, gene-set
constraints can reduce the number of hypothesis tests and thus
have the potential to enhance the statistical power of high-order
SNP combination search. However, the reduction of search space
based on prior knowledge also risks missing novel combinations
that are not supported by known gene sets. This calls for a
quantitative estimation of the tradeoff. Leveraging the efficiency
and scalability of the proposed framework, we design the following
experiments to explore how gene-set constraints improve the
statistical power of high-order SNP combination search (see
methods section about how to incorporate gene-set constraints in
DPM), where the power is measured indirectly by the number of
combinations and unique SNPs discovered with respect to a false
discovery rate based on permutation tests as described in the
method section. We use the 1892 gene sets from the Molecular
Signature Database (MSigDB, C2) [24] as the source of biological
constraints.
Table 1 summarizes the comparison we designed on the three
real datasets. We compared the without-constraint setup (A) with
two variations of with-constraint setups, one with a SupMaxPair
threshold that is the same with setup A (0.2, the lowest threshold
that DPM can finish within 0.5 hour without gene-set
constraints) and the other with a threshold (0.1, the lowest
threshold that DPM can finish within 0.5 hour with gene-set
constraints) that is lower to demonstrate that the gain of
computational efficiency with gene-set constraints allows the
search for combinations with lower frequency. The latter two
setups are denoted as B and C respectively. To study how the
size of gene sets affects the statistical power of the proposed
framework, we use a parameter (MaxGeneSetSize) to select the
gene sets to use in each experiment. Specifically, for each dataset,
we conducted the experiments in B and C with
MaxGeneSetSize~20,40,60,80 and 100 respectively. Note that,
we only vary MaxGeneSetSize below 100 because we observed
that when gene sets have more than 100 genes, there are few if
any statistically significant (with FDR (w.r.t. x2) below 0.25) SNP
combinations (with respect to permutation-based FDRs). Several
key observations can be made from Table 1.
A key observation is that, gene-set constraints are generally
effective for improving the statistical power of high-order SNP
combination discovery. For Survival, none of the discovered
combinations have FDR (w.r.t. x2) below 0.25 in the without-
constraint setup. In contrast, with the gene-set constraints, there
are tens of significant (with FDR (w.r.t. x2) below 0.25) SNP
combinations discovered (all of size-2). On the other two datasets,
although the without-constraint setup discovers more significant
combinations than the with-constraint setups, additional SNPs can
be discovered in the with-constraint setups, as indicated by the
second numbers in the brackets.
However, gene-set constraints sometimes can miss interesting
SNP combinations. For the dataset Kidney, without-constraint
setup discovers 98 statistically significant SNP combinations
(with FDR (w.r.t. x2) below 0.25) of sizes 3 and 4 (permutation-
test based FDR less than 0.25 after correcting for multiple
hypothesis tests), while the two with-constraint setups only
discover 2 and 6 combinations with FDR (w.r.t. x2) below 0.25
(all of size 2), respectively. The possible explanation is that the
gene sets in MSigDB C2 may not describe the functional
pathways related to the phenotype in the Kidney dataset
(rejection vs. no-rejection for the patients with kidney trans-
plant). This observation indicates that the effectiveness of gene-
set constraints depends on the gene sets used and varies from
phenotype to phenotype.
A final observation is that, setup C (with-constraint using lower
SupMaxPair) allows the search of lower-frequency SNP
combinations. Specifically, on Kidney and Survival, more
significant SNP combinations with FDR (w.r.t. x2) below 0.25
are discovered when the lower SupMaxPair (0.2) is used. This
demonstrates the existence of low-frequency yet statistically
significant SNP combinations and thus the benefits of searching
low-support SNP-combinations, which is enabled by using gene-
set constraints.
Exploring Functional Interactions in High-order
Combinations
Existing work that studies functional interactions in SNP
combinations mostly focuses pairs of loci [18,57–60]. The few
studies that explored functional interactions in high-order
combinations are mostly based on SNP datasets that cover a
Figure 4. Comparison between the FDRs without x2{jump based filtering and the FDRs with x2{jump filtering for the Lungcancer
and Kidney datasets respectively. In both subfigures, each circle represent a SNP combination. There are several circles sitting below the line
y~x, indicating that they have lower (more significant) FDR when a x2{jump filtering is applied compared to the case where no x2{jump is used.
doi:10.1371/journal.pone.0033531.g004
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on one or a few top ranked combinations discovered from a single
dataset and thus only reveal disease-specific functional interactions
[17,41]. In this study, before interpreting the top high-order SNP
combinations, we first explore functional interactions in SNP
combinations from a more general perspective. The aim is to
exploit some common insights on functional interactions in
discriminative SNP combinations consistent across multiple
datasets which may provide some guidance for future studies.
Positive connection between x2
jump and within-pattern
functional coherence. Specifically, we study how the increase
of discriminative power of a SNP combination over its subsets is
related to the functional coherence of the genes covered by the
combination. For this purpose, we divide all the discriminative
patterns discovered by SMP into three groups, i.e. those having
x2
jump values in z5, z? ½Þ , {5, z5 ðÞ and {?, {5 ð  (denoted
as GP1, GP2 and GP3 respectively) and study the relative
functional coherence of the patterns in the three groups. To
measure the functional coherence of a SNP combination, we first
obtain the set of genes covered by the combination by assigning a
SNP to its closest gene, and then determine the functional
similarity between each unique pair of genes covered by the
combination using a human functional network integrated from a
comprehensive set of resources [61]. Essentially, such an
estimation decomposes the functional coherence of a set of genes
covered by a SNP combination into the functional similarities of
the set of unique gene pairs. We prefer this approach to a GO
enrichment analysis [62] because: 1) the former can provide more
detailed functional insights on gene-gene interactions within high
order combinations, and 2) the latter is usually applicable to gene
sets that are of sizes larger than the high-order SNP combinations
discovered in this study (size-3, 4 or 5, Figure 3). With the
decomposition-based approach for each SNP combination, we can
get three distributions of gene-gene functional similarities for the
three groups of SNP combinations GP1, GP2 and GP3
respectively, where each distribution contains the functional
similarities of the union (unique) of the within-pattern gene pairs
from all the patterns in one of the three groups. In addition to the
three distributions, we also generate a null distribution (R1)b y
repeating the following procedure 100 times: we randomly sample
gene pairs from the set of genes covered in the corresponding
dataset as many as the number of gene pairs in GP1, while fixing
the number of times each unique gene occurs with respect to GP1.
Because we binarize the human functional network [61] at 0.5
(The corresponding network has a density of 5%) to make the size
of the network efficient to manage). It is worth noting that the
following results are consistent across different cutoff values for the
functional network (0.5, 0.6, 0.7 and 0.8).
Figure 5 summarizes the comparison among the four distribu-
tions in term of the fraction of functional similarities above 0.5 and
the p-values of the ranksum tests for (GP1 vs. GP3) and (GP1 vs.
R1). The comparisons are done on the Kidney and Lungcancer
dataset but not on Survival because there are significant SNP
combinations (with FDR (w.r.t. x2) below 0.25) discovered on the
former two but not the latter as shown in Figure 3. A key
observation is that GP1 has higher within-pattern functional
similarity than both R1 and GP3: This is reflected by the
consistently higher fraction of within-pattern gene pairs with
functional similarity scores above 0.5 in GP1 than in R1 and GP3:
The relative order among GP1, GP3 and R1 is significant
(ranksum test p values as shown in the figure) and consistent on the
datasets Kidney and Lungcancer as well as the combined.
(Datasets Kidney and Lungcancer cover the same set of genes
and thus have the same null distribution of gene-pair functional
similarity. Therefore, we combine the each of the four sets of gene
pairs (GP1, GP2, GP3 and R1) from the two datasets to increase
the sample size and allow a more reliable estimation of p value.)
This observation provides a novel positive connection between the
Table 1. Parameters used and number of significant patterns discovered for each of the three datasets, for evaluating the effects
of gene-set constraints on enhancing statistical power after correcting multiple hypothesis tests.
Data Name Exp NO.
Gene Set
Constrains Patt Size MaxGeneSetSize
20 40 60 80 100
Kidney A N 2 2(3)
3 64(61)
4 34(50)
B Y 2 2 ( 3 , 3 ) 0 000
C Y 2 0 0 0 6 (10,5) 0
Survival A N 0
B Y 2 2(3,3) 2(3,3) 2(3,3) 5(8,8) 3(5,5)
C Y 2 5(7,7) 11(14,14) 7(10,10) 7(10,10) 11(17,17)
Lungcancer A N 2 14(12)
57 ( 1 2 )
B Y 2 12(10,7) 0 0 0 0
3 0 0 0 6(10,10) 8(16,13)
C Y 2 0 4(6,6) 4(6,6) 5(8,8) 0
Parameters used and number of significant patterns discovered with respect to the FDR cutoff 0:25 for each of the three approaches (A: without constraint,
SupMaxPair ~0:2; B: with constraints, SupMaxPair ~0:2 and C: with constraints, SupMaxPair ~0:1) on each of the four real datasets. The number outside the
brackets are the number of significant patterns discovered, and the first number inside a bracket shows the number of unique SNPs covered by the patterns (note that
there are overlaps between patterns); the second number inside the s bracket (for approaches B and C only) indicates the number of SNPs that are discovered by
approaches B or C but not by approach A in the corresponding dataset, thus indicating the benefit of using gene-set constraints.
doi:10.1371/journal.pone.0033531.t001
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subsets and the functional coherence among the genes covered by
the combination. Essentially, this set of observations suggest that
x2
jump not only improves the statistical power of the discriminative
SNP-combinations search framework (as shown in earlier), it is
also indicative on the biological relevance of the genes covered by
discriminative SNP combinations. The fact that GP3 has the
lowest fraction of functional scores above 0.5 further supports that
a x2
jump-based filtering is helpful and important for further
exploration of functional insights from discriminative SNP
combinations. The results are consistent across different cutoff
values for the functional network (0.5, 0.6, 0.7 and 0.8).
It is worth noting that, GP1 and GP2 have about the same
fraction of functional scores above 0.5 on both Kidney and
Lungcancer and the ranksum tests between them are insignificant
(ranksum test) on both datasets. This suggests that the genes
covered by a SNP combination with x2
jump around zero also tend to
be functionally related. This may be explained by existing study on
positive yeast genetic interactions [63] where multiple genetic
perturbations targeted on a single pathway are often found to have
similar effect as the genetic perturbation of just one gene in the
pathway. In contrast, the SNP combinations with x2
jump highly
above zero (GP1) may correspond to the genes that are involved
with multiple pathways that have compensation with each other,
or correspond to the genes on a single pathway but with dosage
effect [63]. To our knowledge, this set of analysis is the first
exploring the connection between discriminative power of SNP
combinations and functional interactions from a general perspec-
tive across multiple datasets.
Specific interpretation of two patterns discovered from
Datasets Lungcancer and Kidney. Beyond the above general
biological insights, we also find that several high-order patterns
with high x2
jump that are biologically interesting with respective to
the complex diseases, e.g. size-5 patterns in the Lungcancer
dataset and size-4 patterns in the kidney dataset. Figure 6
illustrates two examples with descriptions similar to Figure 1: a
size-5 pattern discovered from Lungcancer with an odds ratio of
11.15, an p-value of 10{8 and a false discovery rate of 0.20, and a
size-4 pattern discovered from Kidney with an odds ratio of 6.31,
an p-value of 10{9:14 and a false discovery rate of 0.21. It is
interesting that the two patterns are both more discriminative than
their subsets. Furthermore, we also found that the synergy,a
measure of statistical epistasis capturing non-additive interactions
[45], of the Lungcancer pattern is positive, indicating a probable
interaction beyond additive effect.
The five SNPs in the Lungcancer pattern are mapped to the five
genes that are closest (chromosome location) to them respectively,
SIM1 [MIM: 63128], PARP1 [MIM: 173870], WT1 [MIM:
607102], ABCC1 [MIM: 158343] and ABCC4 [MIM: 605250].
Four out of the five genes (the latter four) are previously known to
be associated with cancer, with the latter three being associated
with lung cancer specifically [64–66]. SIM1 has been shown to
interact with ARNT [MIM: 126110], which binds to Aryl
Hydrocarbon Receptor (AHR [MIM: 600253]), and the AHR
pathway has been recently shown to be activated upon binding of
various exogenous chemicals from cigarette smoke and might link
to lung cancer risk [67]. PARP1 is a poly(ADP-ribose)
polymerases-1, involved with DNA repair and has been associated
with both better survival in non-small cell lung cancer, as well as
with increased risk of lung cancer [68]. PARP1 is becoming an
important target for cancer therapy, as inhibitors of PARP have
low toxicity [69]. There was also a group that showed that
transcriptional activation of PARP1 leads to in-silica malignant
transformation of human bronchial epithelial cells [70]. WT1
(Wilms tumor 1) has been shown to be a critical regulator of
senescence and proliferation downstream of oncogenic KRAS
signaling [71], and KRAS [MIM: 190070] is one of the most
frequently mutated human oncogenes. ABCC1 and ABCC4 are
ATP-binding cassette genes, sub-family C, involved with multi-
drug resistance [72] so their association with lung cancer here
might have something to do with therapy. Discovering these five
SNPs together as a highly predictive combination with an odds
ratio of 11:15, and a large x2
jump of 7.9 may provide novel insights
on their combined effects (beyond their separate effects) on their
association with lung cancer. The top molecular interaction
network (using Ingenuity Pathway Analysis (http://www.
ingenuity.com, accessed 2012 Feb 20)) for this Lungcancer pattern
is also shown. This molecular subnetwork is associated with cell
death and cell cycle function with the top enriched disease being
cancer, and therefore supports the functional interaction among
the set of genes and their joint association with the risk of lung
cancer. The other pattern in Figure 6 (size-4) is discovered on the
Kidney dataset (XRCC4 [MIM: 194363], SLC7A7 [MIM:
603593], XRCC1 [MIM: 194360] and ITGB3 [MIM: 173470]).
The four gene corresponding to the four SNPs are also enriched
with a molecular interaction network with annotations closely
Figure 5. Functional similarity of within-combination gene pairs in three groups of discriminative SNP combinations and the null
distributions (best view in color). This is to reveal the connection between x2{jump and within-combination functional coherence. The six
comparisons, a{f, and the associated ranksum test p-values are also shown.
doi:10.1371/journal.pone.0033531.g005
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abnormalities, cellular movement, cellular-mediated immune
response and cellular development.
It is worth noting that such statistically significant and
biologically relevant discriminative SNP combinations are mostly
high-order combinations of common variants (those SNPs with
high allele frequencies). While the current focus in the exploration
of the genetics of rare diseases is mostly on individually rare
variants, these high-order SNP combinations indicate that
common variants could also be the cause of rare diseases because
combinations of common variants can be a rare composite variant.
Discussion
We presented a computational framework for searching high-
order SNP combinations with strong disease association from case-
control datasets with thousands of SNPs. The framework is
substantially more efficient and scalable than existing techniques
that usually handle tens of or hundreds of SNPs and mostly up to
size-3 combinations. We further showed that, while most high-
order combinations are trivial extensions of their subsets, there are
indeed high-order combinations in real datasets and they have
stronger associations with some disease phenotypes beyond single
SNPs and low-order SNP combinations. We also evaluated the
effect of two strategies for enhancing the statistical power of high-
order SNP combination search: filtering out SNP combinations
with lower or similar discriminative power than their subsets and
constraining the search space with known biological gene sets.
Further leveraging the improved statistical power of this
framework, we explored the functional interactions within the
SNP combinations discovered from three real case-control datasets
and revealed a positive connection between the increase of
discriminative power of a SNP combination over its subsets and
the functional coherence among the genes covered by the
combination. Last but not least, we investigated two representative
high-order SNP combinations (one of size-5 and the other of size-
4) discovered from a lung cancer case-control dataset and a kidney
transplant-rejection case-control dataset respectively, and showed
that the genes covered by the two patterns are enriched with
molecular interaction networks that are highly relevant to the risk
of lung cancer and risk of rejection after kidney transplant,
respectively. These results demonstrate the ability of our approach
to find statistically significant and biologically relevant high-order,
patterns, but we likely find only a subset of all possible SNP
patterns of interest. In particular, some interesting patterns could
be eliminated during the discriminative pattern mining step or in
the x2
jump filtering step. Other existing approaches may discover
some of these missed patterns, but likely miss many of the high-
order patterns we find. Thus, what we provide is a well-founded
and efficient (even though not complete) approach to pattern
discovery in SNP datasets.
Given that there has been a lack of tools for higher-order
combination analysis due to computational and statistical
challenges, the proposed framework is expected to help discover
Figure 6. Visualization of two SNP-genotype combinations discovered from the Lungcancer and Kidney datasets respectively. The
interpretation is similar to the subfigures in Figure 5. The rsnumbers of the five SNPs in the Lungcancer pattern and the four SNPs in the Kidney
pattern (all with MM genotype) are shown. The SNPs in the two patterns are mapped to the following two sets of genes, (SIM1, PARP1, WT1,
ABCC1, ABCC4) and (XRCC4, SLC7A7, XRCC1 and ITGB3). The x2 statistics of the pattern and its subsets are shown in the right subfigures.
Their permutation test-based FDRs and odds ratios are also shown. The top enriched molecular interaction network (by Ingenuity Pathway Analysis)
is also shown for each pattern, where the shaded nodes are those genes mapped from the SNPs in each pattern.
doi:10.1371/journal.pone.0033531.g006
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proaches that mostly take the route of univariate analysis,
pathway/network enrichment analyses that are based on univar-
iate statistics, or epistasis analysis of low-order SNP combinations.
In addition to the proposed framework itself, some general
observations made in this study could also help the development of
other computational techniques that search for high-order SNP
combination and exploit functional insights, namely: 1) two
strategies for enhancing statistical power to cope with multiple
hypothesis testing in the combinatorial search could be leveraged
by other approaches, 2) the observed positive connection between
the increase of discriminative power of a combination beyond its
subsets and the within-pattern functional coherence, both of which
may guide more comprehensive exploration of functional insights
of high-order interaction, and 3) the observation that many
significant associations are rare combinations of common
variations, which suggests an alternative direction to explore the
genetics of rare diseases for which current focus is on individually
rare variations.
The three real datasets used in this paper represent a type of
studies that have a different perspective from the typical disease-
control designs used in most genome-wide association studies
(GWAS). Specifically, the case-control designs used in the three
studies are the short vs. long survival of multiple myeloma patients
(all received the same treatment), acute rejection after kidney
transplant (all received the same treatment) and patients with lung
cancer and normal subjects (all heavy smokers). Studies with such
or similar designs enforce strict additional criteria in sample
selection and thus normally have much fewer samples compared
to most GWAS studies. Given the limited sample sizes, the three
studies adopted a SNP chip that targets a set of SNPs selected on
the basis of biological candidacy in order to have better statistical
power. Therefore, we expect the proposed framework to help
other studies that also use targeted SNP chips to search for high-
order SNP combinations that provide insights beyond univariate
or lower-order analysis.
The proposed framework is able to efficiently search high-order
combinations for focused studies with thousands of SNPs, but not
directly suitable for focus studies with even more SNPs (e.g. tens of
thousands) or genome-wide data. However, note that, this
limitation is not specific to the proposed approach but to high-
order interaction discovery in general, because there it is
computationally infeasible to search for high-order interactions
directly from genome-wide SNP datasets. After all, the state of the
art methods for discovering high-order interactions could only
handle less than a thousand SNPs as reviewed in the paper.
Nevertheless, a practical solution to handle genome-wide datasets
is to apply the current framework on a subset of SNPs selected by
some prioritization strategy [7], e.g. adopt tag SNP selection [50]
techniques to first obtain a set of less redundant SNPs, or only
search for high-order interactions involving those that have
sufficient marginal effects as done in [38,39], or only search for
high-order interactions among the SNPs within a certain category
based on prior biological knowledge, e.g. a pathway or a genomic
region, etc.
There are several possibilities for future work. First, we used a
binary encoding for SNP-genotype combinations which differen-
tiates the present of all the SNP genotypes in a pattern in a subject
from the mismatch of any one genotype, but not further
distinguish different numbers of mismatches. A more generalized
encoding [73] that reflect the numbers of mismatches can be
incorporated into the DPM framework and further explored.
Second, the current study only assigns a SNP to the closest gene
when exploring the functional similarity within a SNP combina-
tion, and thus may ignore the effect of a SNP on affected genes
located far from the SNP (e.g. long distance cis-regulation or trans-
regulation). In future work, one could integrate SNP data with
gene expression data (when available) to map eQTLs before
studying functional interactions within a SNP combination [74].
Third, because the current framework cannot automatically
handle datasets with a large imbalance of race or gender between
cases and controls, we only analyzed datasets with balanced or
slightly imbalanced populations by requiring a large minimum
differentiation threshold and only considered autosomal SNPs in
order to avoid trivial discoveries. To make the current framework
more widely applicable, we could select a subset of cases and
controls to enforce a balance of population structure based on
genome-wide autosomal clustering [26] or we could explore some
generalization approaches that have been used to allow MDR to
automatically handle confounding factors and continuous traits
[18]. Last but not least, although this study focused on the
discovery of high-order combinations from SNP datasets, a similar
framework could also be applied for discovering combinations of
other formats of genetic variations such as copy number variations
or epigenetic variations such as DNA methylation, or even more
generally across different types of (epi)genetic variations.
Materials and Methods
Three SNP Datasets and Pre-processing Considerations
We carefully checked the race and gender information in the
three datasets to make sure the high-order combinations are not
due to spurious allelic association as suggested by [75,76].
Specifically, the subjects in the first two datasets are all Caucasian
descendants and the last dataset contains both Caucasian and
African American samples with an 9% imbalance between the
cases and controls. We require the minimum differentiation
between cases and controls to be 15% in all the SNP-combination
search and analysis, in order to avoid the discovery of trivial
difference due to population substructure, and we only consider
SNPs from autosomes to remove the effect of gender imbalance.
As shown in the result section, the comprehensive functional
analysis on the discovered SNP patterns also supports that the
discovered SNP combinations are functionally related to the
disease instead of confounding factors such as gender and race.
SNPs with more than 5% missing values are also removed.
Simulation of a Synthetic Case-control SNP Dataset
We first used Hap-Sample simulator (http://www.hapsample.
org, accessed 2012 Feb 20) to simulate genotype data with the
3404 SNPs from a recent study on multiple myeloma [34] as input,
out of which 2172 SNPs are included in Hap-Sample. The
synthetic dataset contains 70 cases and 70 controls (randomly
generated from the HapMap project [77]). Note that this genotype
dataset by itself does not contain disease-associated loci.
Therefore, as a proof of concept we further embedded four
synthetic high-order SNP combinations of size 3,4,5 and 6
respectively, that are associated with the case-control grouping,
as shown in Figure S2 (with similar description as those shown in
Figure 1). To study the scalability of SMP with respect to sample
size (summarized in Figure S3), we further generated another 6
synthetic datasets with sample size (cases and controls combined)
from 280 to 5600 in seven steps (280, 420, 560, 1400, 2800 and
5600). In each of the additional six datasets, we first use Hap-
Sample simulator to generate SNP genotypes for more samples.
Then, we embedded the same four synthetic patterns as done in
the first data but increasing the number of samples while
maintaining the frequency of each SNP genotype in the cases
High-Order SNP Combinations and Complex Diseases
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supplementary website.
The Apriori Framework: Efficient Combinatorial Search
with Anti-monotonic Objective Function
The Apriori framework is essentially a bottom-up exhaustive
combinatorial search framework initially designed for association
analysis on binary data. It first searches all the size-2 combinations
and then moves up to size-3 and so on. Different from brute-force
search, the Apriori framework leverages the antimonotonicity of
the objective function for pruning the combinatorial search space.
Specifically, an objective function F is anti-monotonic if the
following equation holds:
Va’5a,F(a)ƒF(a’), ð2Þ
where a is any combination of SNPs with the binary encoding
described in the result section. An anti-monotonic objective
function can be used in the Apriori algorithm to efficiently traverse
the combinatorial search space without the need of visiting all the
nodes in the search space, because as soon as F(a’) is found to be
disqualified with respect to a threshold (t) (i.e. F(a’)ƒt), Apriori
can prune all the supersets of a’ without missing any combination
with an F value greater than t, given that the anti-monotonicity of
F guarantees that F(a)ƒF(a’)ƒt, Va6a’. Further details on the
optimized implementation of the Apriori framework can be found
in [47].
The Anti-monotonic Objective Function SupMaxPair
Given a case-control dataset, the SupMaxPair of a SNP
combination a (with the binary encoding described in the result
section) is defined in [48] as below (assuming the combination is
more frequent in the cases; similarly for the other situation when
the combination is more frequent in the controls):
SupMaxPair(a)~Supcases(a){max i,j fg [a(Supcontrols( i,j fg ))ð3Þ
where Sup(X) denotes the frequency (in percentage) of a SNP
combination in a set of samples, cases or controls as shown in the
subscript. So, SupMaxPair(a) is defined as the difference between
the frequency of a SNP combination in the cases and the maximal
frequency of its size-2 subsets in the controls. An objective function
defined in this way not only captures the frequency difference of a
SNP combination between the cases and controls, but also has the
antimonotonicity property, because the difference between an
anti-monotonic function (frequency Sup(X)) and a monotonic
function max is anti-monotonic (refer to [48] for the formal proof).
Using SupMaxPair in the Apriori framework guarantees the
discovery of all the SNP combinations that show at least some
frequency differentiation between cases and controls on the size-2
level, as controlled by a threshold on SupMaxPair: Therefore, if a
size-5 combination does not show any differentiation until size-3
(or size-4, size-5) SupMaxPair would miss it. As shown by a recent
theoretical study [51], the possibility that a high-order (size-k)
combination with strong differentiation shows zero differentiation
in all of its subsets decreases dramatically when k increases
(generally become impossible for k greater than 5). Therefore, in
practice, we can use a threshold on SupMaxPair as low as
possible (computationally more and more expensive) as long the
computational time is still acceptable, in order to minimize the
chance of missing interesting high-order interactions.
Permutation Tests and Estimation of the False Discovery
Rate (FDR)
Because of the large number of high-order SNP combinations
tested in the search process, correction for multiple hypotheses
testing is needed for a reasonable estimation of the statistical
significance of the discovered SNP combinations. We follow the
widely used empirical permutation-based approach (e.g. as used in
[24]) to estimate false discovery rates (FDRs). Specifically, we first
apply the proposed algorithm to the data with the original case-
control grouping to get a set of discriminative patterns which are
called the real patterns. Next, in each permutation test, we randomly
shuffle the grouping of subjects into cases and controls while
maintaining the original sample-size ratio between cases and
controls, and then use SMP with exactly the same setup as for the
original case-control grouping to discover a set of patterns. If x2
jump
based filtering and gene set-based constraints are used for the
original case-control grouping, the same procedures are also
applied in each permutation in order to have an unbiased
correction of multiple hypothesis testing. We repeat the permu-
tation tests 100 times and get 100 lists of discriminative patterns
which are called the random patterns. For each pattern (both real and
random ones), we compute a x2 statistic. The false discovery rate
(FDR) of a real pattern (with respect to a x2 statistic of c and
of size-k) is then calculated as follows: if there are m real patterns of
size-k with x2 greater than c and there are n random patterns of
size-k with x2 statistic greater than c, then the false discovery rate is
n=(100   m): Note that, the run with real case-control label and
each of the runs with randomized case-control label test the same
number of hypotheses even though different number of combina-
tions were pruned in the searching process.
Note that, in the above permutation based FDR computation,
the estimation of FDR is specific to the pattern size. The use of
size-specific FDR is motivated by the fact that it is harder and
harder for a combination to provide additional discriminative
power than all of its subsets as size increases. That is, given the
same threshold of x2
jump, it is less likely to discover a larger
combination than to discover a smaller one. This is supported by
the observations made in Figure 2 as well as our recent work in
[51] from a more theoretical perspective. In addition, this is in
accord with the observations made by Ma et al. [33]. Therefore,
we chose to estimate size-specific FDRs to better reflect the
statistical significance of patterns of larger sizes. It is worth noting
that estimating FDRs for combinations of different sizes separately
might also increase the risk of discovering false positives. While
one conservative approach is to do a second round of correction
on multiple hypothesis testing over different combination sizes, we
highlight the potential of discovering novel biological insights from
a hypothesis generation perspective in this study. Indeed, the
independent functional analyses presented in the result section
with the discovered high-order combinations do support that the
genes covered by the discovered combinations have significant
functional relationship compared to the carefully controlled null
distribution. Ma et al. [33] also proposed to include the subsets of
a pattern for estimating its null distribution in addition to the
random patterns discovered in the permutation tests. However in
this paper, we estimate FDRs only with the random patterns
discovered in the permutation tests because we directly enforce the
requirement that a pattern has a sufficiently larger x2
jump than its
subsets.
Applying Gene-set Constraints in DPM
Gene-set constraints have been used in some recent work [38] to
improve computational efficiency and to make the biological
interpretation of results easier. Essentially, a set of SNPs are
High-Order SNP Combinations and Complex Diseases
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around the genes that are on a common pathway or interact with
each other. Similar constraints can also be applied with molecular
interaction networks, where the search is limited to a local
subnetwork within a certain diameter. For example, human
protein-protein interaction networks are used in in genome-wide
SNP data analysis to reduce the search space of two-locus
interactions [46]. It is worth noting that gene-set or molecular-
subnetwork constraints also has antimonotonicity (if a set of SNPs
do not belong to any gene set or molecular subnetwork, it is
guaranteed that its supersets are not qualified either). Therefore,
these constraints can be naturally incorporated together with
SupMaxPair in the SMP framework to search for high-order
patterns [48].
Supporting Information
Figure S1 Transforming a toy SNP dataset in categorical
representation to the corresponding binary representation.
(TIF)
Figure S2 Four synthetic discriminative patterns of size-36 that
we embed in the synthetic dataset as described in the method
section, with similar description as Figure 1.
(TIF)
Figure S3 The scalability of SMP with respect to sample size
(cases and controls combined). The computational time of SMP
increases linearly with the sample size (Note that the x-axis is not
linearly spaced).
(TIF)
Table S1 Summary of the three real datasets. The second
column lists the number of SNPs for each dataset after filtering out
the SNPs with more than 5% missing values.
(DOC)
Table S2 The effect of sample sizes on the FDRs of the four
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